Comparison of Two Ventilator Mode During the Night: New Strategy of Mechanical Ventilation Weaning (NCT01573481) | Clinical Trial Compass
CompletedNot Applicable
Comparison of Two Ventilator Mode During the Night: New Strategy of Mechanical Ventilation Weaning
France19 participantsStarted 2012-01
Plain-language summary
The purpose of the study is to compare pressure controlled continuous mandatory ventilation versus pressure support ventilation during the night for weaning to mechanical ventilation in chronic obstructive pulmonary disease patients and their impact onto sleep quality.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The patient and/or legal representative of the patient has provided a written informed consent before inclusion in the study
* The patients is hospitalized in respiratory and critical care unit (university hospital of AMIENS, FRANCE)
* the patient is mechanically ventilated (ventilator model : puritan-bennett B840)
* Pulmonary disease,chronic obstructive (Spirometry and Blood Gas Analysis in chronic state before admission)
* stable cardiovascular status (cardiac frequency \< 140 beats/min and systolic blood pressure : 90-160 mmHg without catecholamines)
* midazolam \< 0,05mg/kg/h
* sufentanyl \< 0,05µ/kg/h
* the disorder that caused respiratory failure and prompted mechanical ventilation is treated
* the clinician suspects the patient may be ready to begin the weaning process
* inspiratory oxygen fraction (FiO2) \< 50%
* positive end-expiratory pressure \< or equal 8cmH2O
* during the day, the patient tolerate pressure support ventilation (pressure support level \< 15cmH2O
* respiratory frequency (FR) \< 35 breaths/min
* tidal volume (VT) \> 5ml/kg
* PaO2/FiO2 \> 200 mmHg
* FR/VT \< 105 breaths/min/L
Exclusion Criteria:
* sleep apnea, central
* narcolepsy
* Encephalopathy, Metabolic AND Encephalitis
What they're measuring
1
Weaning duration
Timeframe: between one to 21 days (the study will begin when patient presents weaning criteria and will stop 48 days after extubation.)